Ambrosio-Albala, Pepa
Stevens, Merel
van Ooij, Caroline
Searle, Beverley
Garcia, Noemi
Jordá, Pilar
Middlemiss, Lucie
van Grieken, Amy https://orcid.org/0000-0001-6767-9159
Funding for this research was provided by:
Horizon 2020 Framework Programme (945097)
Article History
Received: 21 November 2024
Accepted: 17 July 2026
First Online: 24 July 2026
Declarations
Ethics approval and consent to participate: The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki. In Leeds and Valencia, a full ethical review was conducted before data collection for the project took place (Ethics committee University of Leeds—AREA (Faculties of Business, Environment and Social Sciences), ref. no. 21–070; Valencia, Spain: Ethics committee for research with medicines of the university clinical hospital of Valencia, ref. no. 2021/316). Regarding the study in Heerlen, The Medical Ethics Committee of Erasmus MC University Medical Center in Rotterdam, The Netherlands, declared that the rules laid down in the Medical Research Involving Human Subjects Act (also known by its Dutch abbreviation WMO), do not apply to this research proposal (Medical Ethical Committee (MEC) – Erasmus University Medical Center Rotterdam, ref. no. MEC-2022–0150). All participants provided informed consent to participate in the study.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.